BioCentury
ARTICLE | Company News

Ligand sales and marketing update

April 24, 1995 7:00 AM UTC

Ligand Pharmaceuticals Inc. (LGND) LGND began Canadian sales of Proleukin interleukin-2 to treat metastatic kidney cancer. The San Diego company's Canadian subsidiary, Ligand Pharmaceuticals (Canada)...